Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1457606444
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 Ave Ponce de Leon Santurce Medical Mall Suit 308
San Juan, PR, 00909
Phone (787) 726-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
378 services
Medicare patients, 2024
120
Average age 75
Drug cost, 2024
$6.1M
12,609 prescriptions
Company payments, 2025
$38K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alex N Gonzalez Bossolo was code 99213 (office e&m - established), 153 times for 71 patients. In total Alex N Gonzalez Bossolo billed 378 services in 13 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 153 | 71 | $58.61 | $8,968 |
| 99232 Hospital E&M - Subsequent | Facility | 151 | 31 | $58.30 | $8,803 |
| 99223 Hospital E&M - Initial | Facility | 29 | 27 | $123.35 | $3,577 |
| 99204 Office E&M - New | Office | 22 | 22 | $108.60 | $2,389 |
By year: 2022 $26K for 359 services; 2023 $24K for 347 services; 2024 $25K for 378 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alex N Gonzalez Bossolo prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,585 prescriptions and refills. In total Alex N Gonzalez Bossolo wrote 12,609 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,585 | 2,469 | 374 | $118K |
| Ozempic Semaglutide | 1,309 | 1,368 | 234 | $1.3M |
| Mounjaro Tirzepatide | 742 | 773 | 119 | $829K |
| Trulicity Dulaglutide | 665 | 722 | 111 | $716K |
| Farxiga Dapagliflozin Propanediol | 545 | 745 | 122 | $431K |
| Atorvastatin Calcium Generic | 539 | 1,152 | 213 | $6,727 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 531 | 845 | 130 | $491K |
| Jardiance Empagliflozin | 518 | 769 | 129 | $468K |
| Glimepiride Generic | 449 | 708 | 127 | $7,032 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 392 | 578 | 100 | $353K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 367 | 486 | 93 | $39K |
| Metformin Hcl Generic | 365 | 647 | 127 | $2,806 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 345 | 699 | 103 | $39K |
| Rosuvastatin Calcium Generic | 314 | 670 | 127 | $4,258 |
| Pioglitazone Hcl Generic | 303 | 495 | 78 | $4,685 |
Brand drugs: 9,090 claims; generic drugs: 3,194 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alex N Gonzalez Bossolo $38K ($38K in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 32 | $18K |
| Lilly USA, LLC LLY | 16 | $17K |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $415 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $363 |
| Novo Nordisk Inc NVO | 17 | $322 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $272 |
| Abbott Laboratories ABT | 15 | $243 |
| Bayer Puerto Rico Inc. BAYN.DE | 11 | $236 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $204 |
| Dexcom, Inc. DXCM | 11 | $186 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.